FRANCHINA, Tindara
FRANCHINA, Tindara
Dipartimento di Patologia Umana dell'adulto e dell'età evolutiva "Gaetano Barresi"
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives
2015-01-01 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria; Picone, Antonio; Ferraro, Giuseppa; Zanghì, Mariangela; Toscano, Giuseppe; Giordano, Antonio; Adamo, Vincenzo
A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients.
2006-01-01 Scandurra, G; Ferraro, Giuseppa; Franchina, Tindara; Chiofalo, G; Zanghi', Mariangela; Festa, V; Pastura, G; Adamo, Vincenzo
Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis.
2010-01-01 Franchina, Tindara; Adamo, Barbara; Caristi, Nicola; G., Chiofalo; G., Toscano; Colonese, Francesca; Denaro, Nerina; Ricciardi, GIUSEPPINA ROSARIA; A., Russo; Adamo, Vincenzo; University, Polyclinic; Messina, Italy; School of, Medicine; University, Polyclinic; Palermo, Italy
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports.
2012-01-01 Franchina, Tindara; Adamo, Barbara; Ricciardi, GIUSEPPINA ROSARIA; Caristi, Nicola; Agostino, RITA MARIA; Proto, Claudia; Adamo, Vincenzo
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database
2022-01-01 Barbieri, M. A.; Sorbara, E. E.; Cicala, G.; Santoro, V.; Cutroneo, P. M.; Franchina, T.; Spina, E.
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients
2015-01-01 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC).
2013-01-01 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ferraro, Giuseppa; Franchina, Tindara; Zanghi', Mariangela; Buda, Carmelo; Trimarchi, Giuseppe; Cardia, R; Tuccari, Giovanni; Adamo, Vincenzo
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy
2017-01-01 Lucchesi, Simona; Marciano', Ilaria; Paolo, Panagia; Intelisano, Rosanna; Maria Pia Randazzo, ; Sgroi, Carmela; Altavilla, Giuseppe; Santarpia, Mariacarmela; Adamo, Vincenzo; Franchina, Tindara; Francesco, Ferraù; Paolina, Reitano; Trifiro', Gianluca
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel
2018-01-01 Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Battaglia, A.; Scimone, A.; Berenato, R.; Giordano, A.; Adamo, V.
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis
2021-01-01 Passiglia, Francesco; Cinquini, Michela; Bertolaccini, Luca; Del Re, Marzia; Facchinetti, Francesco; Ferrara, Roberto; Franchina, Tindara; Larici, Anna R.; Malapelle, Umberto; Menis, Jessica; Passaro, Antonio; Pilotto, Sara; Ramella, Sara; Rossi, Giulio; Trisolini, Rocco; Novello, Silvia
Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy.
2006-01-01 Adamo, Vincenzo; Franchina, Tindara; Adamo, Barbara; Scandurra, G; Scimone, Andrea
Can we better manage advanced NSCLC in the elderly with the new therapeutic agents? Preliminary analysis of a real life multicenter study.
2017-01-01 Franchina, T; Novello, S; Russo, A; Gianetta, M; Capelletto, E; Galetta, D; Catino, A; Migliorino, Mr; Ricciardi, S; Morgillo, F; Della Corte, Cm; Rocco, D; Soto Parra, Hj; Russo, A; Ambrosio, F; Franchina, V; Adamo, V
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance
2016-01-01 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Ferraro, Giuseppa; Scimone, Antonino; Bronte, Giuseppe; Russo, Antonio; Rolfo, Christian; Adamo, Vincenzo
Challenges and promises of physical exercise in advances lung cancer patients
2018-01-01 Franchina, T.; Russo, A.; Ricciardi, G. R. R.; Righi, M.; Franchina, V.; Adamo, V.; Magaudda, L.
Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer.
2014-01-01 Franchina T; Amodeo V; Bronte G; Savio G; Ricciardi GR; Picciotto M; Russo A; Giordano A; Adamo V.
Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients.
2012-01-01 Gangemi, Sebastiano; Minciullo, PAOLA LUCIA; Adamo, Barbara; Franchina, Tindara; Ricciardi, GIUSEPPINA ROSARIA; Ferraro, M; Briguglio, Roberta; Toscano, G; Saitta, Salvatore; Adamo, Vincenzo
Correction: Androgen Receptor (AR), E-cadherin, and Ki-67 as emerging targets and novel prognostic markers in Triple-Negative Breast Cancer (TNBC) patients
2015-01-01 Ricciardi, Giuseppina Rosaria Rita; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper
2022-01-01 Faggiano, A.; Mazzilli, R.; Natalicchio, A.; Adinolfi, V.; Argentiero, A.; Danesi, R.; D'Oronzo, S.; Fogli, S.; Gallo, M.; Giuffrida, D.; Gori, S.; Montagnani, M.; Ragni, A.; Renzelli, V.; Russo, A.; Silvestris, N.; Franchina, T.; Tuveri, E.; Cinieri, S.; Colao, A.; Giorgino, F.; Zatelli, M. C.
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper
2023-01-01 Silvestris, N; Franchina, T; Gallo, M; Argentiero, A; Avogaro, A; Cirino, G; Colao, A; Danesi, R; Di Cianni, G; D'Oronzo, S; Faggiano, A; Fogli, S; Giuffrida, D; Gori, S; Marrano, N; Mazzilli, R; Monami, M; Montagnani, M; Morviducci, L; Natalicchio, A; Ragni, A; Renzelli, V; Russo, A; Sciacca, L; Tuveri, E; Zatelli, M C; Giorgino, F; Cinieri, S
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
2020-01-01 Passiglia, F.; Bertolaccini, L.; Del Re, M.; Facchinetti, F.; Ferrara, R.; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Pilotto, S.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives | 1-gen-2015 | Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria; Picone, Antonio; Ferraro, Giuseppa; Zanghì, Mariangela; Toscano, Giuseppe; Giordano, Antonio; Adamo, Vincenzo | |
| A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients. | 1-gen-2006 | Scandurra, G; Ferraro, Giuseppa; Franchina, Tindara; Chiofalo, G; Zanghi', Mariangela; Festa, V; Pastura, G; Adamo, Vincenzo | |
| Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis. | 1-gen-2010 | Franchina, Tindara; Adamo, Barbara; Caristi, Nicola; G., Chiofalo; G., Toscano; Colonese, Francesca; Denaro, Nerina; Ricciardi, GIUSEPPINA ROSARIA; A., Russo; Adamo, Vincenzo; University, Polyclinic; Messina, Italy; School of, Medicine; University, Polyclinic; Palermo, Italy | |
| Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. | 1-gen-2012 | Franchina, Tindara; Adamo, Barbara; Ricciardi, GIUSEPPINA ROSARIA; Caristi, Nicola; Agostino, RITA MARIA; Proto, Claudia; Adamo, Vincenzo | |
| Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database | 1-gen-2022 | Barbieri, M. A.; Sorbara, E. E.; Cicala, G.; Santoro, V.; Cutroneo, P. M.; Franchina, T.; Spina, E. | |
| Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients | 1-gen-2015 | Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo | |
| Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). | 1-gen-2013 | Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ferraro, Giuseppa; Franchina, Tindara; Zanghi', Mariangela; Buda, Carmelo; Trimarchi, Giuseppe; Cardia, R; Tuccari, Giovanni; Adamo, Vincenzo | |
| Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy | 1-gen-2017 | Lucchesi, Simona; Marciano', Ilaria; Paolo, Panagia; Intelisano, Rosanna; Maria Pia Randazzo, ; Sgroi, Carmela; Altavilla, Giuseppe; Santarpia, Mariacarmela; Adamo, Vincenzo; Franchina, Tindara; Francesco, Ferraù; Paolina, Reitano; Trifiro', Gianluca | |
| Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel | 1-gen-2018 | Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Battaglia, A.; Scimone, A.; Berenato, R.; Giordano, A.; Adamo, V. | |
| Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis | 1-gen-2021 | Passiglia, Francesco; Cinquini, Michela; Bertolaccini, Luca; Del Re, Marzia; Facchinetti, Francesco; Ferrara, Roberto; Franchina, Tindara; Larici, Anna R.; Malapelle, Umberto; Menis, Jessica; Passaro, Antonio; Pilotto, Sara; Ramella, Sara; Rossi, Giulio; Trisolini, Rocco; Novello, Silvia | |
| Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy. | 1-gen-2006 | Adamo, Vincenzo; Franchina, Tindara; Adamo, Barbara; Scandurra, G; Scimone, Andrea | |
| Can we better manage advanced NSCLC in the elderly with the new therapeutic agents? Preliminary analysis of a real life multicenter study. | 1-gen-2017 | Franchina, T; Novello, S; Russo, A; Gianetta, M; Capelletto, E; Galetta, D; Catino, A; Migliorino, Mr; Ricciardi, S; Morgillo, F; Della Corte, Cm; Rocco, D; Soto Parra, Hj; Russo, A; Ambrosio, F; Franchina, V; Adamo, V | |
| Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance | 1-gen-2016 | Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Ferraro, Giuseppa; Scimone, Antonino; Bronte, Giuseppe; Russo, Antonio; Rolfo, Christian; Adamo, Vincenzo | |
| Challenges and promises of physical exercise in advances lung cancer patients | 1-gen-2018 | Franchina, T.; Russo, A.; Ricciardi, G. R. R.; Righi, M.; Franchina, V.; Adamo, V.; Magaudda, L. | |
| Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. | 1-gen-2014 | Franchina T; Amodeo V; Bronte G; Savio G; Ricciardi GR; Picciotto M; Russo A; Giordano A; Adamo V. | |
| Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. | 1-gen-2012 | Gangemi, Sebastiano; Minciullo, PAOLA LUCIA; Adamo, Barbara; Franchina, Tindara; Ricciardi, GIUSEPPINA ROSARIA; Ferraro, M; Briguglio, Roberta; Toscano, G; Saitta, Salvatore; Adamo, Vincenzo | |
| Correction: Androgen Receptor (AR), E-cadherin, and Ki-67 as emerging targets and novel prognostic markers in Triple-Negative Breast Cancer (TNBC) patients | 1-gen-2015 | Ricciardi, Giuseppina Rosaria Rita; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo | |
| Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper | 1-gen-2022 | Faggiano, A.; Mazzilli, R.; Natalicchio, A.; Adinolfi, V.; Argentiero, A.; Danesi, R.; D'Oronzo, S.; Fogli, S.; Gallo, M.; Giuffrida, D.; Gori, S.; Montagnani, M.; Ragni, A.; Renzelli, V.; Russo, A.; Silvestris, N.; Franchina, T.; Tuveri, E.; Cinieri, S.; Colao, A.; Giorgino, F.; Zatelli, M. C. | |
| Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper | 1-gen-2023 | Silvestris, N; Franchina, T; Gallo, M; Argentiero, A; Avogaro, A; Cirino, G; Colao, A; Danesi, R; Di Cianni, G; D'Oronzo, S; Faggiano, A; Fogli, S; Giuffrida, D; Gori, S; Marrano, N; Mazzilli, R; Monami, M; Montagnani, M; Morviducci, L; Natalicchio, A; Ragni, A; Renzelli, V; Russo, A; Sciacca, L; Tuveri, E; Zatelli, M C; Giorgino, F; Cinieri, S | |
| Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines | 1-gen-2020 | Passiglia, F.; Bertolaccini, L.; Del Re, M.; Facchinetti, F.; Ferrara, R.; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Pilotto, S.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S. |